(Q34452827)

English

Relevance of platinum-sensitivity status in relapsed/refractory extensive-stage small-cell lung cancer in the modern era: a patient-level analysis of southwest oncology group trials

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Relevance of platinum-sensitivity status in relapsed/refractory extensive-stage small-cell lung cancer in the modern era: a patient-level analysis of southwest oncology group trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

1 reference

based on heuristic

inferred from title

Thomas J Semrad

object named as

Thomas J Semrad

4

0 references

object named as

Karen Kelly

5

0 references

David R Gandara

9

object named as

David R Gandara

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

author name string

Primo N Lara

1

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

James Moon

2

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Mary W Redman

3

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Jeffrey W Allen

6

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Barbara J Gitlitz

7

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Philip C Mack

8

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

publication date

1 January 2015

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Journal of Thoracic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

110-115

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Southwest Oncology Group S0802: a randomized, phase II trial of weekly topotecan with and without ziv-aflibercept in patients with platinum-treated small-cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4320001

6 July 2018

Phase II trial of temozolomide in patients with relapsed sensitive or refractory small cell lung cancer, with assessment of methylguanine-DNA methyltransferase as a potential biomarker

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4320001

6 July 2018

Sorafenib in Platinum-Treated Patients with Extensive Stage Small Cell Lung Cancer: A Southwest Oncology Group (SWOG 0435) Phase II Trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4320001

6 July 2018

Relative Risk Trees for Censored Survival Data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4320001

6 July 2018

Comparison of second-line treatment outcomes between sensitive and refractory small cell lung cancer patients: a retrospective analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4320001

27 October 2018

Management of recurrent small cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4320001

27 October 2018

A phase II study of topotecan and docetaxel in patients with sensitive relapse small cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4320001

27 October 2018

Bortezomib (PS-341) in relapsed or refractory extensive stage small cell lung cancer: a Southwest Oncology Group phase II trial (S0327).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4320001

27 October 2018

Phase II multicenter trial of voreloxin as second-line therapy in chemotherapy-sensitive or refractory small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/25490004

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Teniposide in the treatment of small-cell lung cancer: the influence of prior chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/25490004

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1097/JTO.0000000000000385

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34452827&oldid=1630945234"